| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/25/2006 | EP1713466A2 Antiparasitic composition containing an organic amine salt of closantel |
| 10/25/2006 | EP1713465A2 Compounds and compositions as lxr modulators |
| 10/25/2006 | EP1713464A2 Glycine and/or proline for use in cartilage affecting conditions |
| 10/25/2006 | EP1713463A2 Reelin deficiency or dysfunction and methods related thereto |
| 10/25/2006 | EP1713462A1 A method of modulating pro-inflammatory and inflammatory activity mediated by c-reactive protein |
| 10/25/2006 | EP1713461A1 Compounds having antitumor activity |
| 10/25/2006 | EP1713460A2 Fk228 analogs and their use as hdac-inhibitors |
| 10/25/2006 | EP1713459A2 Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases |
| 10/25/2006 | EP1713458A1 Method for enhancing the bioavailability of ospemifene |
| 10/25/2006 | EP1713457A2 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 10/25/2006 | EP1713456A1 Rectal composition |
| 10/25/2006 | EP1713455A2 Method for producing sorbicillactone a |
| 10/25/2006 | EP1713452A2 Sustained release pharmaceutical composition of indapamide |
| 10/25/2006 | EP1713451A1 Solid dosage formulations of galanthamine |
| 10/25/2006 | EP1713447A1 Particulate plant sterol compositions |
| 10/25/2006 | EP1713445A2 Non-lamellar compositions of dioleoyl phosphatidylethanolamine and polysorbate 80 |
| 10/25/2006 | EP1713444A1 A microemulsion preparation of high concentration propofol for anesthetic uses |
| 10/25/2006 | EP1713443A2 Nanosuspensions of anti-retroviral agents for increased central nervous system delivery |
| 10/25/2006 | EP1713439A1 Pharmaceutical preparation for the oral cavity |
| 10/25/2006 | EP1713337A2 Modulation of line-1 reverse transcriptase |
| 10/25/2006 | EP1669357A4 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof |
| 10/25/2006 | EP1662965A4 Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane |
| 10/25/2006 | EP1654262B1 7-azaindole derivatives as cox2 inhibitors |
| 10/25/2006 | EP1590346B1 4- {'3-(sulfonylamino) phenyl] '1-(cyclymethyl) piperidin-4-ylidene] methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 10/25/2006 | EP1567501B1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors |
| 10/25/2006 | EP1562609B1 Inositolized phospholipids |
| 10/25/2006 | EP1560830B1 Derivatives of [6, 7-dihydro-5h-imidazo[1,2 - a]imidazole -3 -sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins |
| 10/25/2006 | EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 10/25/2006 | EP1532152B1 Novel polymorph of n-methyl-n-(3- 3- 2-thienylcarbonyl|-pyrazol- 1,5-alpha|-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto |
| 10/25/2006 | EP1524971B1 Improved transdermal delivery system |
| 10/25/2006 | EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 10/25/2006 | EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same |
| 10/25/2006 | EP1509231A4 Peritoneal dialysis solution with taurolidine |
| 10/25/2006 | EP1501925A4 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 10/25/2006 | EP1490030B1 Nanoparticulate compositions of angiogenesis inhibitors |
| 10/25/2006 | EP1458718B1 Quinolinones as prostaglandin receptor ligands |
| 10/25/2006 | EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN |
| 10/25/2006 | EP1420880A4 Stabilization and terminal sterilization of phospholipid formulations |
| 10/25/2006 | EP1416949B1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba |
| 10/25/2006 | EP1401824B1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 10/25/2006 | EP1401416B1 Use of c-kit inhibitors for treating inflammatory bowel diseases (ibd) |
| 10/25/2006 | EP1392689B1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
| 10/25/2006 | EP1383511B1 Calcilytic compounds |
| 10/25/2006 | EP1370543B1 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 10/25/2006 | EP1363951B1 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
| 10/25/2006 | EP1332155B1 Immunization of dairy cattle with gapc protein against streptococcus infection |
| 10/25/2006 | EP1326617B9 Use of 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-one for the preparation of a medicament for the treatment fo breast, ovarian, endometrial cancer, myeloma and meningioma |
| 10/25/2006 | EP1315721B1 A thiazolidinedione derivative and its use as antidiabetic |
| 10/25/2006 | EP1315488B1 Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions |
| 10/25/2006 | EP1313476B1 Sgk3 used as diagnostic and therapeutic target |
| 10/25/2006 | EP1286672B1 S-methyl-dihydro-ziprasidone for the treatment of ocular disorders. |
| 10/25/2006 | EP1278522B1 Pde-v inhibitors for treatment of parkinson's disease |
| 10/25/2006 | EP1265849B1 Compounds and methods to treat alzheimer's disease |
| 10/25/2006 | EP1265606B1 Cell adhesion inhibitors |
| 10/25/2006 | EP1219632B1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 10/25/2006 | EP1187613B9 Amide substituted imidazoquinolines |
| 10/25/2006 | EP1157006B1 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists |
| 10/25/2006 | EP1143930B1 Pharmaceutical formulation of fluticasone propionate |
| 10/25/2006 | EP1129112B1 Peptides containing a cholesterol recognition sequence and their uses |
| 10/25/2006 | EP1097167B1 Neurotrophic growth factor |
| 10/25/2006 | EP1089998B1 Epothilone derivatives and their synthesis and use |
| 10/25/2006 | EP0912086B1 Method of screening for drugs for the treatment of alzheimer's disease |
| 10/25/2006 | EP0828849B1 High-affinity oligonucleotide ligands to pdgf |
| 10/25/2006 | CN1852988A Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 10/25/2006 | CN1852979A Modulation of eIF4E expression |
| 10/25/2006 | CN1852926A Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them |
| 10/25/2006 | CN1852918A Methods and compositions for interferon therapy |
| 10/25/2006 | CN1852915A Purine nucleoside analogues for treating flaviviridae including hepatitis c |
| 10/25/2006 | CN1852914A Novel indolopyrrolocarbazole derivative with antitumor activity |
| 10/25/2006 | CN1852913A Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 10/25/2006 | CN1852912A Novel 14 and 15 membered-ring compounds |
| 10/25/2006 | CN1852911A Epimeridinoside A and epimeredi indica root extract preparation containing same and preparing method therefor |
| 10/25/2006 | CN1852907A 2-amino-5-benzoylthiazole npy antagonists |
| 10/25/2006 | CN1852905A N-substituted benzimidazolyl c-kit inhibitors |
| 10/25/2006 | CN1852904A Endurance improving agent |
| 10/25/2006 | CN1852901A Organic compounds |
| 10/25/2006 | CN1852900A 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 10/25/2006 | CN1852899A Polymorphic forms of a known antihyperlipemic agent |
| 10/25/2006 | CN1852897A Gabanergic modulators |
| 10/25/2006 | CN1852896A Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 10/25/2006 | CN1852894A Crystalline forms of [R-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid |
| 10/25/2006 | CN1852893A (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof |
| 10/25/2006 | CN1852890A Abiotic heparin antagonists |
| 10/25/2006 | CN1852881A Benzotropolone derivatives and modulation of inflammatory response |
| 10/25/2006 | CN1852749A Use of dapsone as a neuroprotector in cerebral infarction |
| 10/25/2006 | CN1852748A Azepine derivatives as pharmaceutical agents |
| 10/25/2006 | CN1852744A Endoluminal prosthesis comprising a therapeutic agent |
| 10/25/2006 | CN1852740A Multi-arm polymer prodrugs |
| 10/25/2006 | CN1852739A Pharmaceutical products comprising bisphosphonates |
| 10/25/2006 | CN1852738A Treatment of gastrointestinal stromal tumors with imatinib and midostaurin |
| 10/25/2006 | CN1852737A Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 10/25/2006 | CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 10/25/2006 | CN1852722A Methods and pharmaceutical compositions for healing wounds |
| 10/25/2006 | CN1852721A Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers |
| 10/25/2006 | CN1852720A Pharmaceutical composition and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist |
| 10/25/2006 | CN1852719A Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate |
| 10/25/2006 | CN1852718A 2-alkylidene-19-nor-vitamin D derivatives for the treatment of frailty, muscle damage or sarcopenia |
| 10/25/2006 | CN1852717A 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteopenia or male osteoporosis |
| 10/25/2006 | CN1852716A Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone |
| 10/25/2006 | CN1852715A Cephem compounds |